| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |